Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global DNA & RNA Banking Services Market, By Service Type
7.1. DNA & RNA Banking Services Market, By Service Type Type, 2020-2030
7.1.1. Transportation Service
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Processing Service
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Storage Service
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Quality Control Service
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Data Storage
7.1.5.1. Market Revenue and Forecast (2016-2030)
7.1.6. Others
7.1.6.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global DNA & RNA Banking Services Market, By Specimen Type
8.1. DNA & RNA Banking Services Market, By Specimen Type, 2020-2030
8.1.1. Blood
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Buccal Swabs & Hair Follicles
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global DNA & RNA Banking Services Market, By Application Type
9.1. DNA & RNA Banking Services Market, By Application Type, 2020-2030
9.1.1. Therapeutics
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Drug Discovery & Clinical Research
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Clinical Diagnostics
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. Other Applications
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global DNA & RNA Banking Services Market, By End-use Type
10.1. DNA & RNA Banking Services Market, By End-use Type, 2020-2030
10.1.1. Academic Research
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Pharmaceutical & Biotechnology Companies
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. Hospitals & Diagnostic Centers
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global DNA & RNA Banking Services Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.1.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.1.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.1.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.1.5.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.1.5.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.1.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.1.6.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.1.6.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.1.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.2.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.2.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.2.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.2.5.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.2.5.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.2.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.2.6.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.2.6.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.2.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.2.7.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.2.7.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.2.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.2.8.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.2.8.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.2.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.3.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.3.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.3.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.3.5.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.3.5.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.3.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.3.6.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.3.6.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.3.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.3.7.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.3.7.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.3.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.3.8.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.3.8.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.3.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.4.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.4.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.4.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.4.5.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.4.5.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.4.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.4.6.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.4.6.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.4.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.4.7.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.4.7.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.4.7.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.4.8.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.4.8.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.4.8.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.5.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.5.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.5.5.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.5.5.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.5.5.4. Market Revenue and Forecast, By End-use Type (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Service Type (2016-2030)
11.5.6.2. Market Revenue and Forecast, By Specimen Type (2016-2030)
11.5.6.3. Market Revenue and Forecast, By Application Type (2016-2030)
11.5.6.4. Market Revenue and Forecast, By End-use Type (2016-2030)
Chapter 12. Company Profiles
12.1. EasyDNA
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. DNA Genotek Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. 23andMe, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. GoodCell
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. ProteoGenex
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. US Biolab Corporation, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Infinity Biologix
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Thermo Fisher Scientific, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. deCODE genetics
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Brooks Life Sciences
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. LGC Biosearch Technologies
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. PreventionGenetics
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms